Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Dolni Brezany

4 clinical trials in Dolni Brezany, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Dolni Brezany at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Dolni Brezany

Open in trial search

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Type 2 diabetes mellitus

Not yet recruiting

Study of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Study of ExPEC9V vaccine for preventing invasive E.

Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ECOO15
  • Sponsor:Janssen Vaccines & Prevention B.V.

Other cities in Czechia

The busiest research cities in the country

All 159 cities in Czechia

Clinical research in Dolni Brezany

What the registry says about research in the country

01 Infectious Disease Research

Clinical investigation focusing on Extraintestinal Pathogenic Escherichia coli infections, specifically targeting prevention strategies in older adults. The research explores innovative vaccine development for individuals with a history of urinary tract infections.

  • Bacterial Disease Prevention
  • Vaccine Development
  • Geriatric Medicine

The study evaluates the effectiveness of a novel ExPEC9V vaccine against multiple bacterial serotypes, aiming to prevent invasive disease in vulnerable populations aged 60 and above.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.